Providing goal-concordant care in the adult ICU
The adjective "goal-concordant" describes clinical care that helps reach a patient-identified goal, and respects any treatment limitations the patient has placed on clinical care (Fig. 1) . Patient goals are individualized, such as living at home, participating in a planned family event, or being surrounded by loved ones at the time of death. Patient goals may thus be distinct from therapeutic goals, such as cure, life prolongation, or palliation [3] . To define potentially achievable goals, the patient or their surrogate(s) must have sufficient prognostic awareness to understand the expected impact of critical illness and treatments on patient survival and subsequent functional outcomes (i.e., physical, cognitive, and mental health status). Because innate patient and family understanding of prognosis is often poor [6] , intensivists carefully explain prognosis, and their uncertainty about prognosis, to help a patient or surrogate identify a potentially achievable patient goal [7] .
The clinical team also explores whether the patient wishes to place any limitations on the treatments used to achieve their goal. For instance, patients may wish to limit the use of mechanical ventilation and cardiopulmonary resuscitation via do not intubate and do not resuscitate (DNI/R) orders. Given the dynamic nature of critical illness and patient/family understanding of prognosis, regular structured communication with patients/families to reassess patient goals and treatment limitations is essential for goal-concordant care [7] .
Measuring the incidence of goal-discordant care for future research Estimating the incidence of goal-discordant care requires data on the following throughout a patient's ICU stay: (1) patient goals, (2) treatment limitations if any, (3) treatments received, and (4) judgments regarding whether each received treatment was concordant with the patient's goals and limitations on treatment.
Collecting data on patient goals and treatment limitations poses multiple challenges. First, many medical record systems lack a standardized location to document patient goals. Goals embedded within lengthy progress notes or family meeting notes are difficult to retrieve and not routinely updated. Second, most critically ill patients lack decision-making capacity, leaving family members to represent their interests. However, many family members are unprepared to act as surrogates [8] and are uncertain or incorrect about patient goals and treatment limitations [9] . Missing data is a problem when patients lack both decision-making capacity and a surrogate. Finally, although many countries have established methods to document treatment limitations through advance directives and code status orders, code status extracted from the medical record may not accurately reflect patients' preferred treatment limitations [10, 11] . Hence for research purposes, data on patient goals and treatment limitations should be collected from patients or their surrogates longitudinally during the ICU stay or retrospectively after discharge by trained research personnel using a standardized questionnaire, recognizing that retrospective collection is prone to social desirability bias and introduces a substantial risk for recall bias.
The medical record can provide data on preferencesensitive treatments [7, 12] of interest to the research team [11] . Ideally, decisions about which treatments are preference-sensitive for clinical research purposes should be determined with patient-family input [12] . Finally, because these treatments are more common in some ICUs than in others, we recommend estimating the incidence rate as the number of goal-discordant treatments per 100 preference-sensitive decisions, and reporting confidence intervals around this estimate (ESM Table 1 ).
Once data on goals, treatment limitations, and treatments are obtained, a method to determine concordance is required. We propose asking two questions: "Was the patient's goal potentially achievable at the time of treatment?" and "Will the treatment help achieve the patient's goal and respect the patient's treatment limitations?" If the answer to both questions is "yes" the treatment is goal-concordant (ESM Table 2 ). For this approach to be valid, trained clinical reviewers should demonstrate high levels of agreement in response to both questions. Recent research suggests that asking raters how confident they are about the achievability of patient goals could facilitate important sensitivity analyses [13] . 
Implications for clinical research
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Achieving consensus on which treatments must be reviewed. Not every treatment Fig. 1 Conceptual framework for clinical research on goal-concordant care in the ICU setting selecting it as a primary outcome. Most interventions target discrete steps in the provision of goal-concordant care ( Fig. 1 ) and in isolation they are unlikely to increase the incidence of goal-concordant treatment. For example, an advance care planning intervention is unlikely to decrease goal-discordant care if ICU clinicians do not routinely elicit and document patient goals. Measuring a more direct effect of the intervention, such as the proportion of patients who report that they have discussed their goals and preferences with their surrogate, is prudent.
Finally, goal concordance is not synonymous with providing treatment perceived as appropriate by clinicians. Clinicians should advocate for the treatment plan they believe is most appropriate given the patient's values [3, 14] . However, patients and their families may set goals that clinicians deride (e.g., patient 5 in ESM Table 2 ). Using the proposed methodology, treatments that keep patient 5 (ESM Table 2 ) alive are categorized as goalconcordant despite the fact that some clinicians may consider these treatments to be inappropriate [15] .
The proposed process of measuring goal-concordance is valuable because it allows researchers to differentiate between patients whose goals or treatment limitations are unknown, whose goals are unachievable, and whose treatment limitations are ignored. We encourage open discussion, deliberate refinement, and rigorous testing of the proposed methodology for measurement in clinical research.
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